Related Experiment Video
Updated: Sep 15, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Severe Relapsing Hailey-Hailey Disease Displaying a Durable Complete Response to Hydroxyurea
1Constantin A. Dasanu, Eisenhower Lucy Curci Cancer Center, 39000 Bob Hope Drive, Rancho Mirage, United States; c_dasanu@yahoo.com.
Hydroxyurea, a treatment for polycythemia vera, unexpectedly resolved Hailey-Hailey disease symptoms in a patient. This suggests hydroxyurea may be a novel therapeutic option for severe, chronic, or relapsing forms of this genetic skin disorder.
Area of Science:
- Dermatology
- Genetics
- Hematology
Background:
- Familial benign chronic pemphigus, or Hailey-Hailey disease, is a chronic, autosomal-dominant genetic skin disorder.
- It is characterized by impaired keratinocyte adhesion, leading to blisters and rashes, often on the neck, torso, and extremities.
- Conventional treatments have limited efficacy, particularly for severe or relapsing forms.
Purpose of the Study:
- To report a case of Hailey-Hailey disease that showed a surprising positive response to hydroxyurea treatment.
- To explore the potential of hydroxyurea as a therapeutic option for refractory Hailey-Hailey disease.
Main Methods:
- A 54-year-old male patient with a long history of severe Hailey-Hailey disease was diagnosed with polycythemia vera.
- He was treated with hydroxyurea for polycythemia vera.
- The patient's Hailey-Hailey disease symptoms were monitored during hydroxyurea therapy.
Main Results:
- The patient experienced complete resolution of Hailey-Hailey disease skin lesions after commencing hydroxyurea treatment.
- The skin condition remained in remission for four years while polycythemia was well-controlled.
- Hydroxyurea was well-tolerated with no significant side-effects.
Conclusions:
- Hydroxyurea may represent a novel and effective treatment for severe, chronic, or relapsing Hailey-Hailey disease.
- This finding warrants further investigation in larger clinical studies.
- The study highlights an unexpected therapeutic benefit of a medication commonly used in hematology.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Continuous Renal Replacement Therapy
Treatment Resistant Cancers
Multipotency of Hematopoietic Stem Cells
Chronic Kidney Disease II: Clinical Manifestations

